Dr Lisa Ann Pitelka, MD | |
1750 W Harrison St, 570 Jelke, Department Of Pathology, Chicago, IL 60612-3825 | |
(312) 942-5260 | |
Not Available |
Full Name | Dr Lisa Ann Pitelka |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 1750 W Harrison St, Chicago, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144476268 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 125.053071 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Lisa Ann Pitelka, MD 74 Westmore Meyers Rd, Lombard, IL 60148-3037 Ph: (815) 483-6422 | Dr Lisa Ann Pitelka, MD 1750 W Harrison St, 570 Jelke, Department Of Pathology, Chicago, IL 60612-3825 Ph: (312) 942-5260 |
News Archive
Though Bangladesh is "on track" to meet most of the Millennium Development Goal (MDG) targets laid out by the U.N., "many female-focused targets, including maternal mortality are lagging far behind," writes Women's eNews, adding that "progress has stalled" at 351 deaths per 100,000, "a point far above the 2014 target figure of 144."
Non-alcoholic fatty liver disease is becoming the most common chronic liver disorder in developed countries. Histological analysis of liver tissue is the only widely accepted test for diagnosing and distinguishing different stages of the disease. However, this technique provides only two-dimensional images of the liver tissue in low resolution and overlooks potentially important 3D structural changes.
CytomX Therapeutics, Inc., a biopharmaceutical company developing Probody therapeutics for the treatment of cancer, today announced the filing of a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock.
Molecular Partners AG, a leader in the development of next generation therapeutics, announced today that it has completed two phase I/IIa clinical trials with MP0112, its lead molecule targeting VEGF-A.
The passage of smoking bans in two large Minnesota cities was not associated with job losses at bars and may in fact have contributed to higher employment in restaurants, according to new research.
› Verified 7 days ago
Mark Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St, Feinberg Pavilion, Chicago, IL 60611 Phone: 312-503-8144 Fax: 312-502-8249 | |
Sandeep Gurbuxani, Pathology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Katrina Krogh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St Ste 7-132i, Chicago, IL 60611 Phone: 312-926-7913 Fax: 312-926-3127 | |
Dr. Carmencita Garcia Senseng, MD Pathology Medicare: Medicare Enrolled Practice Location: 1900 W Polk St, Chicago, IL 60612 Phone: 312-864-7561 | |
Suman Setty, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Jayme Brentan, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Megan Elizabeth Sullivan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-926-3211 |